S 3165
Requires NJ FamilyCare to reimburse inpatient providers for long-acting injectable antipsychotic drugs at outpatient reimbursement rate.
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed General Assembly
- To Governor
- Became Law
Bill overview
This bill requires New Jersey FamilyCare to reimburse inpatient providers at the same rate they reimburse outpatient providers for long-acting injectable antipsychotic drugs. Currently, inpatient providers are reimbursed using a Diagnostic Related Group (DRG) system, which doesn’t fully account for the cost of these medications. By aligning the reimbursement rate, the bill aims to improve access to these medications for patients in inpatient settings and potentially reduce hospital readmissions.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Nicholas Scutari
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.